Virus and cancer
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
21
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
6
Hepatitis C virus infection and risk of cancer: a population-based cohort study
8
Oncolytic virus therapy for cancer
16
Cervical Cancer and HIV Diseases Co-dynamics with Optimal Control and Cost Effectiveness
13
A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers
13
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis
9
Modeling the spatiotemporal dynamics of virotherapy and immune response as a treatment for cancer
14
Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review
11
Epidemiology of cervical cancer with special focus on India
10
Comparison of Molecular (PCR) and Pap Smear Methods in Diagnosis of Human Papiloma Virus (HPV) in Women with Genital Warts
7
Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus.
7
No Evidence for Xenotropic Murine Leukemia-Related Virus Infection in Sweden Using Internally Controlled Multiepitope Suspension Array Serology
12
Virus production by Abelson murine leukemia virus-transformed lymphoid cells.
11
The 150 most important questions in cancer research and clinical oncology series: questions 86–93
7
Conditionally replicating herpes vectors for cancer therapy
7
Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion
11
Promising oncolytic agents for metastatic breast cancer treatment
11
Perspectives on immunotherapy via oncolytic viruses
8
Exploring the virus metaphor in corruption theory: Corruption as a virus?
11